Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04935710 · ClinicalTrials.gov registry record · NA

Prevention and Early Identification for High Risk Youth in School-based Clinics

A NA study, sponsored by Cambridge Health Alliance.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT04935710: Completed NA study, sponsored by Cambridge Health Alliance.

NCT04935710 is a NA study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04935710, a NA study, has completed, sponsored by Cambridge Health Alliance.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

The proposed research project provides a novel approach to screening, early assessment, and preventive interventions for high-risk youth in racial/ethnic/linguistically (REL)-diverse communities. * The investigators assess a health promotion intervention as a way of reducing treatment disparities in REL-minority youth. This population is underrepresented in child psychiatry research. It is often excluded from clinical trials of medication or therapy because of challenges with transportation, literacy, resources, or other issues. * The study will take place during or following a healthcare crisis and economic recession, making findings relevant to understanding the mechanisms by which hardship translates into youth mental illness. * The innovative integration of online screening into school-based clinics and community-based settings in REL-minority communities is made possible by the combination of access to a new technology (CAT) in the context of a learning health community serving a REL-minority population. * Empirical research on the impact of a resilience-based prevention intervention in youth and youth at risk is both innovative and much needed during this period of health, social and economic crisis.

Primary Outcome

The K-CAT-S is a computerized adaptive test for assessment of DSM 5 conditions in youth. Adaptive testing allows the assessment to be done in less than 10 minutes with high validity compared against diagnostic interviews. High scores indicate greater psychopathology. For each of six domains, the minimum score is 0, a score between 45-64 is moderate, a score greater than 65 is severe, and the maximum score is 100. For this primary outcome, the Total K-CAT was used, adding scores across all six do

Interventions

  • OTHER Usual care
  • BEHAVIORAL COPE2Thrive

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2022-01-03
Est. Completion 2024-03-31
Phase NA
Cambridge Health Alliance

45 total trials

What the finished NCT04935710 record still lists

NCT04935710 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT04935710 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04935710 about?

NCT04935710 is a clinical study titled "Prevention and Early Identification for High Risk Youth in School-based Clinics". The proposed research project provides a novel approach to screening, early assessment, and preventive interventions for high-risk youth in racial/ethnic/linguistically (REL)-diverse communities. * The investigators assess a health promotion intervention as a way of reducing treatment disparities i...

What is the current status of trial NCT04935710?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2022-01-03. Estimated completion is 2024-03-31.

What interventions are being tested in trial NCT04935710?

The interventions under investigation include: Usual care (OTHER), COPE2Thrive (BEHAVIORAL).

Who is sponsoring clinical trial NCT04935710?

This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04935710's enrollment target sits among peer trials

39 1536th of 2000 higher than 463 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04935710, the US trial registry maintained by the National Library of Medicine. NCT04935710 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.